17 December 2020 – Our opinion on Sars-Cov-2 vaccines on SIMeF journal
Luigi Aurisicchio, CEO of Takis, and Lucio Rovati, CEO of Rottapharm biotech, interviewed on the journal of SIMeF – Società Italiana di Medicina Farmaceutica.
They talked about the contribution of Italian research to the race for a vaccine against Sars-Cov-2 and pointed out the strengths and critical issues of the vaccines under study, their production and clinical experimentation .
Italy is among the leading countries in the development of a vaccine. We believe that investments in innovation are fundamental engine of the economic growth of a developed country.
Read the interview here
or click on image